| Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis CJL Murray, KS Ikuta, F Sharara, L Swetschinski, GR Aguilar, A Gray, ... The Lancet 399 (10325), 629-655, 2022 | 6964 | 2022 |
| Rapid molecular detection of tuberculosis and rifampin resistance CC Boehme, P Nabeta, D Hillemann, MP Nicol, S Shenai, F Krapp, ... New England Journal of Medicine 363 (11), 1005-1015, 2010 | 3103 | 2010 |
| Leptospirosis: a zoonotic disease of global importance AR Bharti, JE Nally, JN Ricaldi, MA Matthias, MM Diaz, MA Lovett, ... The Lancet infectious diseases 3 (12), 757-771, 2003 | 3046 | 2003 |
| Repurposed antiviral drugs for Covid-19—interim WHO solidarity trial results WHO Solidarity Trial Consortium New England journal of medicine 384 (6), 497-511, 2021 | 2640 | 2021 |
| Resazurin Microtiter Assay Plate: Simple and Inexpensive Method for Detection of Drug Resistance in Mycobacterium tuberculosis JC Palomino, A Martin, M Camacho, H Guerra, J Swings, F Portaels Antimicrobial agents and chemotherapy 46 (8), 2720-2722, 2002 | 1447 | 2002 |
| Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre … CC Boehme, MP Nicol, P Nabeta, JS Michael, E Gotuzzo, R Tahirli, ... The lancet 377 (9776), 1495-1505, 2011 | 1407 | 2011 |
| El nuevo Coronavirus y la pandemia del Covid-19 C Maguiña Vargas, R Gastelo Acosta, A Tequen Bernilla Revista Médica Herediana 31 (2), 125-131, 2020 | 942 | 2020 |
| Multidrug-resistant tuberculosis and culture conversion with bedaquiline AH Diacon, A Pym, MP Grobusch, JM de los Rios, E Gotuzzo, I Vasilyeva, ... New England Journal of Medicine 371 (8), 723-732, 2014 | 855 | 2014 |
| Human T-lymphotropic virus 1: recent knowledge about an ancient infection K Verdonck, E González, S Van Dooren, AM Vandamme, G Vanham, ... The Lancet infectious diseases 7 (4), 266-281, 2007 | 807 | 2007 |
| Recommendations for Treatment of Human Infections Caused by Bartonella Species JM Rolain, P Brouqui, JE Koehler, C Maguina, MJ Dolan, D Raoult Antimicrobial agents and chemotherapy 48 (6), 1921-1933, 2004 | 631 | 2004 |
| Antimicrobial activity of selected Peruvian medicinal plants R Rojas, B Bustamante, J Bauer, I Fernández, J Albán, O Lock Journal of ethnopharmacology 88 (2-3), 199-204, 2003 | 572 | 2003 |
| Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America CA Kauffman, B Bustamante, SW Chapman, PG Pappas Clinical Infectious Diseases 45 (10), 1255-1265, 2007 | 556 | 2007 |
| Rapid and durable antiretroviral effect of the HIV-1 integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of … M Markowitz, BY Nguyen, E Gotuzzo, F Mendo, W Ratanasuwan, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 46 (2), 125-133, 2007 | 534 | 2007 |
| Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1 … JM Molina, J Andrade-Villanueva, J Echevarria, P Chetchotisakd, J Corral, ... The Lancet 372 (9639), 646-655, 2008 | 531 | 2008 |
| Epidemiology of candidemia in Latin America: a laboratory-based survey M Nucci, F Queiroz-Telles, T Alvarado-Matute, IN Tiraboschi, J Cortes, ... PloS one 8 (3), e59373, 2013 | 480 | 2013 |
| Challenges in the diagnosis and management of neonatal sepsis A Zea-Vera, TJ Ochoa Journal of tropical pediatrics 61 (1), 1-13, 2015 | 462 | 2015 |
| Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis A Vassall, S van Kampen, H Sohn, JS Michael, KR John, S den Boon, ... PLoS medicine 8 (11), e1001120, 2011 | 405 | 2011 |
| The laboratory diagnosis and follow up of strongyloidiasis: a systematic review A Requena-Méndez, P Chiodini, Z Bisoffi, D Buonfrate, E Gotuzzo, ... PLoS neglected tropical diseases 7 (1), e2002, 2013 | 396 | 2013 |
| Immune reconstitution inflammatory syndrome: more answers, more questions SA Shelburne, M Montes, RJ Hamill Journal of Antimicrobial Chemotherapy 57 (2), 167-170, 2006 | 394 | 2006 |
| Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis AA Lambert, JO Lam, JJ Paik, C Ugarte-Gil, MB Drummond, TA Crowell PloS one 10 (6), e0128004, 2015 | 386 | 2015 |
